Dr. Tyrone C. Malloy: Research and Studies

Abnormal Pap                       A Randomized, Single Blind, Placebo Controlled Phase 2 Study to assess the Safety of ADXS XXXX for the Treatment of Cervical Intraepithelial Neoplasia Grade 2/3

                                                Principal Investigator

                                                Sponsor: Advaxis  

                                                A randomized, double blind, placebo controlled, parallel group, multicenter study of the safety and response rate of 3 subcutaneously administered doses of X in patient with high grade cervical intraepithelial neoplasia grade 2 or 3 associated with High Risk HPV infection

                                                Principal Investigator

                                                Sponsor: Roche

Randomized, Placebo-Controlled Phase 2 Study of Multiple Dosing Regimens of Intravaginally Administered X Gel for the Treatment of Cervical High Risk HPV Infection

                                                Principal Investigator                                    

Sponsor: Takeda Global Research

A Multi-Center Prospective Clinical Study to Evaluate the Performance and Clinical Predictive Value of the Invaderâ HPV HR Molecular Assay and Invaderâ HPV 16/18 Molecular Assay for the Detection of Human Papilloma Virus in Cervical Cytology Samples

                                                Principal Investigator

Sponsor: Third Wave Technologies   

Abortion/Family

Planning                                 Acceptability and Feasibility of                                

                                                Early Pregnancy Termination by

                                                Mifepristone-Misoprostol.                 

                                                Principal Investigator                                                

                                                Low Dose Mifepristone Plus Vaginal

                                                Misoprostol for Abortion up to 63

                                                Days Gestation.

                                                Principal Investigator

                                                A Copy Mifepristone Product Plus                                                                                                     Misoprostol for Medical Induction

                                                of  Early Abortion: Low Dose

                                                Mifepristone Trial.

                                                Principal Investigator